NEW
YORK, Oct. 17, 2023 /PRNewswire/
-- ExcelFin Acquisition Corp. ("we", "us", "our", or the
"Company"), today announced that the Special Meeting originally
scheduled for October 18, 2023 (the
"Special Meeting") is being adjourned to October 20, 2023. At the Special Meeting, the
Company's stockholders will be asked:
- to consider and vote upon a proposal to amend the Company's
amended and restated certificate of incorporation (the "Charter")
pursuant to a second amendment to the Charter (the "Extension
Amendment") to extend the date by which the Company must effectuate
an initial business combination from October
25, 2023 (the "Termination Date") to April 25, 2024, comprised of an initial
three-month extension and three subsequent one-month extensions,
for a total of six months after the Termination Date (assuming the
Company's initial business combination has not occurred); and
- to consider and vote upon a proposal to adjourn the Special
Meeting to a later date or dates, if necessary, to (i) permit
further solicitation and vote of proxies if, based upon the
tabulated vote at the time of the Special Meeting, there are not
sufficient votes to approve one or more proposals presented to
stockholders for vote or (ii) if stockholders have elected to
redeem an amount of shares in connection with the Extension
Amendment such that the Company would not adhere to the continued
listing requirements of The Nasdaq Global Market ("Nasdaq") (the
"Adjournment Proposal").
As a result of this change, the Special Meeting will now be held
at 10:00 a.m., Eastern Time, on
October 22, 2023, exclusively via
live webcast at the following
address: https://web.lumiagm.com/276796335.
The record date for the stockholders to vote at the Special
Meeting remains the close of business on September 22, 2023 (the "Record Date").
Stockholders who have previously submitted their proxy or otherwise
voted and who do not want to change their vote need not take any
action. Stockholders as of the Record Date can vote, even if they
have subsequently sold their shares. In connection with the
adjourned date, the Company has further extended the deadline for
holders of the Company's Class A common stock issued in the
Company's initial public offering to submit their shares for
redemption in connection with the Special Meeting to 5:00 p.m. Eastern Time on October 18, 2023. Stockholders who wish to
withdraw their previously submitted redemption request may do so
prior to the rescheduled meeting by requesting that the transfer
agent return such shares.
About ExcelFin Acquisition Corp.
ExcelFin Acquisition Corp. is blank check company formed for the
purpose of effecting a merger, capital stock exchange, asset
acquisition, stock purchase, reorganization or similar business
combination with one or more businesses.
Additional Information and Where to Find It
The definitive proxy statement has been mailed to the Company's
stockholders. INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ
THE DEFINITIVE PROXY STATEMENT AND OTHER RELEVANT MATERIALS BECAUSE
THEY CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY. Investors and
security holders may obtain free copies of these documents and
other documents filed with the SEC at the SEC's web site at
www.sec.gov. In addition, the documents filed by Company with the
SEC may be obtained free of charge by contacting Company at 100
Kingsley Park Dr., Fort Mill, South
Carolina 29715. If you have questions about the proposals or
if you need additional copies of the Proxy Statement you should
contact our proxy solicitor:
Morrow Sodali LLC
333 Ludlow Street, 5th Floor, South
Tower
Stamford, Connecticut 06902
Stockholders may call toll-free: (800) 662-5200
Banks and Brokerage Firms, please call: (203) 658-9400
Email: xfin.info@investor.morrowsodali.com
Participants in the Solicitation
Company and its sponsor, officers and directors may be deemed to
be participants in the solicitation of proxies from Company
stockholders. Information about Company's sponsor, officers and
directors and their ownership of Company common stock is set forth
in the proxy statement for Company's Special Meeting of
Stockholders, which was filed with the SEC on September 26, 2023, and in Company's Annual
Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC
on March 30, 2023. Investors and
security holders may obtain more detailed information regarding the
direct and indirect interests of the participants in the
solicitation of proxies in connection with the transaction by
reading the preliminary and definitive proxy statements regarding
the transaction, which were filed by Company with the
SEC.
Non-Solicitation
This press release is not a proxy statement or solicitation of a
proxy, consent or authorization with respect to any securities or
in respect of the Special Meeting shall not constitute an offer to
sell or a solicitation of an offer to buy the securities of the
Company, nor shall there be any sale of any such securities in any
state or jurisdiction in which such offer, solicitation, or sale
would be unlawful prior to registration or qualification under the
securities laws of such state or jurisdiction. No offer of
securities shall be made except by means of a prospectus meeting
the requirements of Section 10 of the Securities Act of 1933, as
amended.
Contacts
Investor Relations
Robin Yang, Partner
ICR, LLC
Phone: +1 (646) 308-1475
Email: BairdMedical.IR@icrinc.com
Public Relations
Brad Burgess, Senior Vice
President
ICR, LLC
Phone: +1 (646) 588-0383
Email: BairdMedical.PR@icrinc.com
View original
content:https://www.prnewswire.com/news-releases/excelfin-acquisition-corp-announces-adjournment-of-special-meeting-301959679.html
SOURCE ExcelFin Acquisition Corp.